NCT01675115View on ClinicalTrials.gov

Efficacy of BNG-1 to Treat Acute Ischemic Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Ischemic Stroke
Interventions
DRUG

BNG-1

BNG-1 3 grams TID for 4 weeks

DRUG

Aspirin

Aspirin 100 mg QD for 4 weeks

Trial Locations (1)

333

Stroke center, Department of Neurology, Linkou Chang Gung Memorial Hospital, Kweishan

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT01675115 - Efficacy of BNG-1 to Treat Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter